CiNTL Pharma B.V. Announces Breakthrough Results from CiNTL.AI Testing in Clinical Trials
November 17, 2024

CiNTL Pharma B.V. Announces Breakthrough Results from CiNTL.AI Testing in Clinical Trials

 

Leiden, The Netherlands, November 17, 2024 – CiNTL Pharma B.V. is proud to announce groundbreaking results from the testing of its AI-powered clinical research platform, CiNTL.AI. The findings reveal that CiNTL.AI has successfully reduced project management time by more than 52%, allowing pharmaceutical companies to significantly cut costs and accelerate clinical trials with greater precision while ensuring compliance with FDA and EMA regulatory standards.

​

“The results of our CiNTL.AI testing mark a major milestone in the evolution of clinical research efficiency,” said Yolanda Cabrera-Sybesma, Chief Executive Officer of CiNTL Pharma B.V. “By leveraging AI-driven automation and data analytics, we are enabling pharmaceutical companies to streamline their trials, optimize resources, and bring life-saving treatments to market faster than ever before.”

​

This breakthrough reinforces CiNTL Pharma’s commitment to integrating cutting-edge technology into the clinical trial landscape. With regulatory approval pathways becoming increasingly complex, CiNTL.AI provides an essential tool for pharmaceutical and biotechnology companies looking to navigate the evolving requirements of the FDA and EMA with precision and confidence.

​

With the demonstrated success of CiNTL.AI in reducing inefficiencies and optimizing trial management, CiNTL Pharma continues to set new industry standards for innovation in clinical research.

For more information about CiNTL Pharma B.V. and its advancements in AI-powered clinical research solutions, visit www.cintlpharma.com.

​

For more information about CiNTL Pharma B.V. and its commitment to AI-driven clinical research innovation, visit www.cintlpharma.com.

​

CiNTL Pharma B.V. is a Contract Research Organization (CRO) that provides clinical research development, consultancy and data driven solution services to the pharmaceutical, biotechnology and life sciences industries.

​​​

For media inquiries, partnerships, or collaborations, please contact CiNTL Pharma Business Development at BD@cintlpharma.com.

​

Witness the future of intelligent clinical research – Experience CiNTL Pharma today.